Ji-Jia Sun (Jijia Sun)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Rheumatoid Arthritis

Molecular Docking

Disease Activity

Machine Learning

Top Venues

BioMed research international

Disease markers

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Ji-Jia Sun, Qinghua Ni, Fengyan Jiang, Baocheng Liu, Jian-Ying Wang, Lei Zhang, Jihan Huang
Discovery and Validation of Traditional Chinese and Western Medicine Combination Antirheumatoid Arthritis Drugs Based on Machine Learning (Random Forest Model). BioMed research international 2023 (2023)
Ji-Jia Sun, Qinghua Ni, Fengyan Jiang, Baocheng Liu, Jian-Ying Wang, Lei Zhang, Jihan Huang
Discovery and Validation of Traditional Chinese and Western Medicine Combination Antirheumatoid Arthritis Drugs Based on Machine Learning (Random Forest Model). BioMed research international 2023 (2023)
Ji-Jia Sun, Bao-Cheng Liu, Rui-Rui Wang, Ying Yuan, Jian-Ying Wang, Lei Zhang
Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine. Disease markers 2022 (2022)
Jiashuai Huang, Linjing Zhao, Ji-Jia Sun, Lixin Wang, Jianrong Gu, Xi-Jian Liu, Mengwen Yang, Yuting Wang, Ning Zhang, Jiamin Zhu, Shanshan Xu, Xinfeng Ren, Ying Su
Clinical Evidence and Potential Mechanisms of Complementary Treatment of Ling Gui Zhu Gan Formula for the Management of Serum Lipids and Obesity. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
null YingHuang, Shan-Shan Gao, Zi-Han Gong, Wen-Jie Li, Xiao-Jun Gou, Ji-Jia Sun, Ming-Jie Sun
Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification. BioMed research international 2022 (2022)
Shan-Shan Gao, Ji-Jia Sun, Xin Wang, Yi-Yang Hu, Qin Feng, Xiao-Jun Gou
Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed research international 2020 (2020)